Health Care & Life Sciences » Pharmaceuticals | Anhui Sunhere Pharmaceutical Excipients Co. Ltd.

Anhui Sunhere Pharmaceutical Excipients Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
212,049.30
237,600.50
256,920.30
283,002.20
335,201.20
424,407.90
Cost of Goods Sold (COGS) incl. D&A
140,463.80
165,490.30
172,230.80
192,721.30
237,827.60
287,754
Gross Income
71,585.50
72,110.20
84,689.60
90,280.90
97,373.70
136,653.90
SG&A Expense
31,682.90
34,845.80
38,087.60
41,630.10
47,840.30
64,713.40
EBIT
38,889.90
35,041.10
49,274.50
51,544.80
49,533.40
71,940.50
Non Operating Income/Expense
1,707.90
5,583.50
6,484.30
3,214.30
5,208.30
10,292.10
Interest Expense
77.50
162.10
151.10
183.40
227.90
221.30
Pretax Income
40,787.00
40,772.90
51,807.20
57,041.70
62,562.20
90,390.70
Income Tax
5,766.70
5,840.40
7,534.30
8,256.10
9,678.60
13,192.30
Consolidated Net Income
35,020.40
34,932.50
44,273.00
48,785.60
52,883.60
77,198.40
Net Income
35,020.40
34,932.50
44,273.00
48,785.60
50,335.80
70,109.50
Net Income After Extraordinaries
35,020.40
34,932.50
44,273.00
48,785.60
50,335.80
70,109.50
Net Income Available to Common
35,020.40
34,932.50
44,273.00
48,785.60
50,335.80
70,109.50
EPS (Basic)
0.34
0.33
0.36
0.35
0.36
0.50
Basic Shares Outstanding
139,199.90
139,199.90
124,129.80
139,199.90
139,199.90
139,200
EPS (Diluted)
0.25
0.25
0.36
0.35
0.36
0.50
Diluted Shares Outstanding
139,199.90
139,199.90
124,129.80
139,199.90
139,199.90
139,200
EBITDA
40,174.20
37,749.80
60,243.80
63,351.60
63,061.20
88,054.50
Other Operating Expense
1,012.70
2,223.30
2,672.50
2,894.00
-
-
Non-Operating Interest Income
266.80
310.40
600.10
1,885.70
6,167.20
6,509
Minority Interest Expense
-
-
-
-
2,547.80
7,088.90

About Anhui Sunhere Pharmaceutical Excipients Co.

View Profile
Address
2 Hebin Road
Huainan Anhui 232007
China
Employees -
Website http://www.shanhe01.com
Updated 07/08/2019
Anhui Sunhere Pharmaceutical Excipients Co., Ltd. engages in the research, development, production, and sale of medical supplements. Its business areas include Pharmaceutical manufacturing and Site lease. Its products include cellulose and its derivative products, starch and its derivative products, and inorganic salts.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.